Kewaunee Scientific (KEQU) Net Cash Flow (2010 - 2026)

Kewaunee Scientific's Net Cash Flow history runs 17 years deep, the most recent figure standing at $1.6 million for Q2 2026.

• On a quarterly basis, Net Cash Flow fell 65.25% year-over-year to $1.6 million in Q2 2026; TTM through Apr 2026 was -$4.6 million, a 46.82% increase from a year earlier, with the FY2026 full-year figure at -$4.6 million, up 46.82% from the prior year.
• Net Cash Flow improved to $1.6 million in Q2 2026 per KEQU's latest filing, from -$3.1 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $15.0 million in Q3 2022 and bottomed at -$17.1 million in Q1 2025.
• The 5-year median for Net Cash Flow is $846000.0 (2022), against an average of $400833.3.
• Biggest YoY gain for Net Cash Flow was 6361.51% in 2022; the steepest drop was 5305.26% in 2022.
• Year by year, Net Cash Flow stood at -$4.9 million in 2022, then jumped by 105.34% to $264000.0 in 2023, then jumped by 1613.64% to $4.5 million in 2024, then sank by 247.83% to -$6.7 million in 2025, then jumped by 123.65% to $1.6 million in 2026.
• Per Business Quant, the three latest KEQU Net Cash Flow figures stand at $1.6 million (Q2 2026), -$3.1 million (Q1 2026), and -$6.7 million (Q4 2025).